HSD17B13 INHIBITORS AND/OR DEGRADERS
Described herein are compounds of Formula I, wherein the variables are defined herein, their use as HSD17B13 inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, NAFLD and NASH. L'invention concerne des composés de formule I, le...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
11.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein are compounds of Formula I, wherein the variables are defined herein, their use as HSD17B13 inhibitors and/or degraders, pharmaceutical compositions containing such compounds and their use to treat, for example, NAFLD and NASH.
L'invention concerne des composés de formule I, les variables étant définies dans la description, leur utilisation en tant qu'inhibiteurs et/ou agents de dégradation de HSD17B13, des compositions pharmaceutiques contenant de tels composés et leur utilisation pour traiter, par exemple, la NAFLD et la NASH. |
---|---|
Bibliography: | Application Number: WO2023IB59988 |